Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 11;7(1):8.
doi: 10.1186/s40813-021-00191-5.

Supplementation of a β-mannanase enzyme reduces post-weaning diarrhea and antibiotic use in piglets on an alternative diet with additional soybean meal

Affiliations

Supplementation of a β-mannanase enzyme reduces post-weaning diarrhea and antibiotic use in piglets on an alternative diet with additional soybean meal

Frédéric Vangroenweghe et al. Porcine Health Manag. .

Abstract

Enzyme supplementation with a β-mannanase to degrade β-mannan fibers present in the diet has been shown to restore and improve performance in swine. The current study was conducted on a farm which had historical episodes of post-weaning diarrhea. In total, 896 newly weaned piglets were enrolled in two consecutive trials. Each trial consisted of 32 pens of 14 piglets housed in one large post-weaning compartment. Piglets at the same feeder were randomly assigned to the two treatment groups. The study compared the performance of post-weaned piglets fed either a commercial 3-phase nursery diet (Control) or an adapted diet supplemented with a β-mannanase (Hemicell HT; Elanco) (Enzyme), with some of the more expensive proteins replaced by soy bean meal in phase 1 and 2, and net energy (NE) content reduced by 65 kcal/kg in phase 3. All data analyses were performed using R version 3.6.3 (R Core Team, 2020). All tests were performed at the 5% level of significance. When multiple testing was involved, the nominal 5% Familywise Error Rate (FWER) was used. The study showed similar performance on the alternative diet with β-mannanase and the common commercial diets (P > 0.05). However, the Enzyme treated group had a significantly better general clinical score. Moreover, the number of individual treatments was a factor exp(0.69441) or 2 (CI 95% [1.46; 2.74]) higher (P < 0.001) in the Control group as compared to the Enzyme treated group. The number of treated animals was a factor exp(0.62861) or 1.87 (CI 95% [1.43; 2.53]) higher (P < 0.001) and the number of pigs with a repeated treatment was a factor exp(0.9293) or 2.53 (CI 95% [1.26; 5.09]) higher (P = 0.009) in the Control group as compared to the Enzyme treated group. In total, 7 (1.56%) piglets died in the Control group, whereas only 2 (0.45%) piglets died in the Enzyme treated group. The hazard ratio for mortality in the Control group relative to the Enzyme treated group was and estimated as 1.74 (CI 95% [0.51; 5.96]). Thus, the Control group had a non-significantly (P = 0.375) increased mortality. In conclusion, the results suggest that the use of an exogenous heat-tolerant β-mannanase allowed reduced levels of expensive protein sources to be used in the first two diets fed post-weaning, and 65 kcal/kg lower net energy content to be used in the third diet without adverse effects on intestinal health or overall performance. In fact, the occurrence of PWD and number of individual treatments during the post-weaning period were significantly reduced on the β-mannanase supplemented diets.

Keywords: Antibiotic reduction; Performance; Protein substitution; Weaned piglets; β-Mannanase.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no other competing interests.

Figures

Fig. 1
Fig. 1
Individual piglet weight (kg; mean ± SEM) at weaning (Start; 0 dpw), first intermediate weighing (End phase 1; 15 dpw), second intermediate weighing (End phase 2; 27 dpw) and end of the trial (Final; 49 dpw). Piglets in the Control group were fed a standard diet, whereas piglets in the Enzyme treated group were fed an adapted diet with more soybean meal in phase 1 and 2, and a decrease level of 65 kcal/kg net energy in phase 3. No significant differences between groups were observed
Fig. 2
Fig. 2
Average fecal clinical score (mean ± SEM) from 0 to 11 dpw. Five relevant fecal droppings were scored daily per pen during the observation period. Piglets in the Control group were fed a standard diet, whereas piglets in the Enzyme treated group were fed an adapted diet with more soybean meal in phase 1 and 2, and a decrease level of 65 kcal/kg net energy in phase 3. No significant differences between groups were observed
Fig. 3
Fig. 3
Average general clinical score (mean ± SEM) from 0 to 11 dpw. Piglets in each pen were scored (0–2) daily during the observation period. Piglets in the Control group were fed a standard diet, whereas piglets in the Enzyme treated group were fed an adapted diet with more soybean meal in phase 1 and 2, and a decrease level of 65 kcal/kg net energy in phase 3. Significant differences (P < 0.05) were indicated with an asterix (*)

References

    1. Cromwell GL. Soybean meal: an exceptional protein source. Arkeny: Soybean Meal InfoCenter; 2017.
    1. Choct M, Dersjant-Li Y, McLeish J, Peisker M. Soy oligosaccharides and soluble non-starch polysaccharides: a review of digestion, nutritive and anti-nutritive effects in pigs and poultry. Asian-Austral J Anim Sci. 2010;23:1386–1398. doi: 10.5713/ajas.2010.90222. - DOI
    1. Ferrel J, Anderson DM, Hsiao H-Y. Content of Soluble Non-Starch Polysaccharides β-Mannan and Xylan in Legume Meals, Non-Legume Meals, and Cereal Grains or Cereal Grain by-products. J Anim Sci. 2014;92:Abstract #328.
    1. Hsiao H-Y, Anderson DM, Dale NM. Levels of β-mannan in soybean meal. Poult Sci. 2006;85:1430–1432. doi: 10.1093/ps/85.8.1430. - DOI - PubMed
    1. Jackson ME, Geronian K, Knox A, McNab J, McCartney E. A dose-response study with the feed enzyme β-mannanase in broilers provided with corn-soybean meal based diets in the absence of antibiotic growth promoters. Poult Sci. 2004;83:1992–1996. doi: 10.1093/ps/83.12.1992. - DOI - PubMed

LinkOut - more resources